Evidence for human diabetic cardiomyopathy

Area of Science:

• Cardiovascular Science
• Endocrinology
• Pathology

Background:

• Diabetes mellitus is linked to a high incidence of heart failure (HF).
• Preclinical models investigate hyperglycemia and insulin resistance effects, but human diabetic cardiomyopathy (DCM) pathogenesis remains unclear.
• Human DCM requires further investigation beyond end-stage, postmortem findings.

Purpose of the Study:

• To analyze existing human data on diabetic cardiomyopathy (DCM).
• To identify key pathogenic events in human DCM.
• To understand the role of lipotoxicity in DCM development.

Main Methods:

• Stringent literature analysis of human DCM data.
• Review of preclinical models and postmortem analyses.
• Focus on early-stage pathogenic events.

Main Results:

• Lipotoxic events appear central to the initiation and progression of human DCM.
• Human DCM data is limited by heart specimen availability.
• Postmortem analyses show end-stage disease, necessitating early-stage investigation.

Conclusions:

• Lipotoxicity is a key factor in human diabetic cardiomyopathy.
• More research is needed on early-stage DCM pathogenesis.
• Understanding early events is crucial for managing heart failure in diabetic patients.